BWAY Earnings Date: Nov 10, 2026 (Estimated) — BrainsWay Ltd.
NASDAQ · Healthcare · Medical Devices
Updated
When is BWAY's next earnings date?
BrainsWay Ltd. (BWAY) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.12 on revenue of $17.8M.
How did BWAY do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), BrainsWay Ltd. posted EPS of $0.07 versus the $0.10 estimate, a miss of 12.5%. Revenue was $17.1M against a $16.5M estimate. The stock's 1-day post-earnings move was +10.8%.
How much does BWAY stock move after earnings?
BWAY beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.3% (up or down) in the day after earnings.
About BrainsWay Ltd.
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | 0.10 | 0.07 | -12.50% | $17.1M | ❌ Miss | +10.81% | -2.14% | -7.14% |
| 2026-05-13 | Q1 2026 | 0.05 | 0.06 | +20.00% | $15.5M | ✅ Beat | -2.57% | -11.05% | -12.25% |
| 2026-03-11 | Q4 2025 | 0.04 | 0.04 | -12.50% | $14.5M | ❌ Miss | +8.34% | +8.03% | +12.51% |
| 2025-11-11 | Q3 2025 | 0.07 | 0.04 | -42.86% | $13.5M | ❌ Miss | -5.83% | -5.83% | +11.04% |
| 2025-08-13 | Q2 2025 | 0.05 | 0.05 | +0.00% | $12.6M | ➖ Inline | +4.18% | +18.70% | +28.79% |
| 2025-03-11 | Q4 2024 | 0.02 | 0.04 | +100.00% | $11.4M | ✅ Beat | +4.68% | +11.10% | -7.83% |
| 2024-08-06 | Q2 2024 | 0.00 | 0.04 | +100.00% | $10.0M | ✅ Beat | +7.82% | +7.20% | +18.62% |
| 2024-05-08 | Q1 2024 | -0.02 | 0.00 | +100.00% | $9.1M | ✅ Beat | -6.40% | -10.02% | +6.73% |
Showing last 8 quarters.